Femtech Market size to exceed $135.5 Bn by 2032

Femtech Market size is anticipated to surpass USD 135.5 billion by 2032, as per a recent research report announced by Global Market Insights Inc.
 

The rising burden of infectious disfeases among the female population will bolster the demand for femtech health solutions. Based on statistics from the World Bank, over 60% of untreated syphilis and HIV infections claim the lives of 200,000 females from unprotected intercourse per year. Due to research and data gaps, breakthroughs in women-specific condition treatment and diagnosis are also limited. This, in turn, is increasing the need for treatment interventions, creating opportunities for femtech app developers to bridge the medical data gap and help collect real-world evidence at scale.
 

Rising use of wearables & women’s health products to promote femtech device development

The products type segment accounted for over 49% of the femtech market share in 2022. Increasing prevalence of chronic and infectious diseases. The popularity of healthcare solutions including wearables and fitness trackers has also surged among women. Over recent years, there has been a noticeable increase in sales of women’s hygiene products. These factors will boost the production of femtech electronics and other wearable products for precise disease diagnosis and treatment of diseases affecting the female population.
 

Browse key industry insights spread across 145 pages with 175 market data tables & 13 figures & charts from the report, “Femtech Market Size By Type (Products, Software, Services), By Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare, General Healthcare & Wellness), By End-use (Direct-to-consumer, Hospitals, Fertility Clinics, Surgical Centers, Diagnostic Centers), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Japan, China, India, Australia, Brazil, Mexico, Saudi Arabia, South Africa), Growth Potential, Competitive Market Share & Forecast, 2023 – 2032”, in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/femtech-market
 

Favorable government initiatives to promote maternity care spur femtech service demand

The pregnancy & nursing care application segment will depict over 16% through 2023-2032, given the widespread availability of advanced pregnancy care solutions. Government bodies have also been undertaking initiatives to promote prenatal care.
 

Preference for surgical and non-surgical treatment to accelerate femtech usage in hospitals

Femtech market value from the hospitals end-use segment was more than USD 6 billion in 2022, owing to the increasing inclination toward surgical and non-surgical procedures for women in hospitals. In addition, women prefer to visit hospitals for the treatment of a range of gynecological disorders, mainly due to the presence of skilled professionals and advanced products. This increased preference for health treatments in hospitals will augment femtech device usage.
 

APAC to emerge as a prominent consumer hub for femtech service providers

Asia Pacific femtech market region is anticipated to hold a 19% business share by 2032. Government bodies in several Asian countries have been introducing favorable initiatives to broaden accessibility to digital health management in remote areas. High-end healthcare technology has also gained ground due to the increasing number of new entrants. The growing spending power of the female population will proliferate the deployment of femtech for improved disease diagnosis and treatments in the region.
 

Strategic partnerships among industry players to bolster the competitive landscape

Major enterprises operating in the femtech industry are BioWink GmbH, Athena Feminine Technologies, Conceivable, Inc, HeraMED, Elvie, iSono Health, Nuvo Cares, Minerva Surgical, Prelude, Sustain Natural, and Totohealth.